BioLine RX Ltd ADR buy melinda
Start price
28.06.16
/
50%
€166.40
Target price
24.08.16
€192.80
Performance (%)
21.91%
End price
24.08.16
€202.85
Summary
This prediction ended on 24.08.16 with a price of €202.85. The prediction had a final performance of 21.91%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BioLine RX Ltd ADR | - | - | - | - |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
According to melinda what are the pros and cons of BioLine RX Ltd ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread BioLine RX Ltd ADR diskutieren
(Zielkurs erreicht)
Stopped prediction by melinda for BioLine RX Ltd ADR
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€2.46
03.11.20
03.11.20
€3.50
04.11.21
04.11.21
-4.88%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€148.15
03.11.18
03.11.18
€284.13
22.01.19
22.01.19
-20.14%
22.01.19
22.01.19
Could be worthwhile Investment >10% per year
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€219.19
18.11.17
18.11.17
€304.43
18.05.18
18.05.18
-14.59%
18.05.18
18.05.18
Could be worthwhile Investment >10% per year
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€217.16
27.01.17
27.01.17
€253.69
16.02.17
16.02.17
20.49%
16.02.17
16.02.17
Could be worthwhile Investment >10% per year